Skip to main content
Erschienen in: International Urology and Nephrology 9/2019

22.06.2019 | Urology - Original Paper

Efficacy and safety of combination of tadalafil and aspirin versus tadalafil or aspirin alone in patients with vascular erectile dysfunction: a comparative randomized prospective study

verfasst von: Zeki Bayraktar, Selami Albayrak

Erschienen in: International Urology and Nephrology | Ausgabe 9/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We aimed to investigate the efficacy and safety of tadalafil, aspirin, and tadalafil + aspirin combination therapy in vascular erectile dysfunction (VED).

Methods

A total of 336 patients were randomly divided into four groups (group 1, aspirin 100 mg/day, 126 patients; group 2, tadalafil 5 mg/day, 72 patients; group 3, tadalafil 5 mg + aspirin 100 mg, 72 patients; group 4, placebo, 66 patients). In all groups, the changes from baseline to end point in erectile function scores on the International Index of Erectile Function (IIEF-EF) and the number of patients who answered “yes” to questions 2 and 3 of the sexual encounter profile(SEP) were compared statistically.

Results

The changes in IIEF-EF scores after treatment were 7.2 ± 4.4, 7.3 ± 4.3, 7.5 ± 4.4, and 2.0 ± 4.6 for group 1 (p < 0.0001), group 2 (p < 0.0001), group 3 (p < 0.0001), and group 4 (p = 0.0204), respectively. The change in SEP-2 ratios after treatment were 36.6%, 36.9%, 41.7%, and 9.4% for group 1 (p < 0.0001), group 2 (p < 0.0001), group 3 (p < 0.0001), and group 4 (p = 0.2925), respectively. The change in SEP-3 ratios after treatment was 46.6%, 49.2%, 53.7%, and 12.5% for group 1 (p < 0.0001), group 2 (p < 0.0001), group 3 (p < 0.0001), and group 4 (p = 0.1456), respectively. In group 2, both the number of patients who reported side effects (p < 0.0001) and stopped using the drug due to side effects (p < 0.05) were significantly higher than the control and others groups.

Conclusions

Successful results were obtained by tadalafil and aspirin monotherapy and tadalafil + aspirin combination therapy in patients with VED. However, the least side effect was observed in the tadalafil + aspirin group. Aspirin can be used alone in the treatment of patients with VED, or combined with tadalafil to reduce side effects and increase success.
Literatur
2.
Zurück zum Zitat Kulkarni SS, Patil CS (2004) Phosphodiesterase 5 enzyme and its inhibitors: update on pharmacological and therapeutical aspects. Methods Find Exp Clin Pharmacol 26:789–799CrossRefPubMed Kulkarni SS, Patil CS (2004) Phosphodiesterase 5 enzyme and its inhibitors: update on pharmacological and therapeutical aspects. Methods Find Exp Clin Pharmacol 26:789–799CrossRefPubMed
4.
Zurück zum Zitat Brock GB, McMahon CG, Chen KK et al (2002) Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol 168:1332–1336CrossRefPubMed Brock GB, McMahon CG, Chen KK et al (2002) Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol 168:1332–1336CrossRefPubMed
5.
Zurück zum Zitat Montorsi F, Verheyden B, Meuleman E et al (2004) Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction. Eur Urol 45:339–345CrossRefPubMed Montorsi F, Verheyden B, Meuleman E et al (2004) Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction. Eur Urol 45:339–345CrossRefPubMed
6.
Zurück zum Zitat Eardley I, Donatucci C, Corbin J et al (2010) Pharmacotherapy for erectile dysfunction. J Sex Med 7:524–540CrossRefPubMed Eardley I, Donatucci C, Corbin J et al (2010) Pharmacotherapy for erectile dysfunction. J Sex Med 7:524–540CrossRefPubMed
7.
Zurück zum Zitat Rajfer J, Aliotta PJ, Steidle CP, Fitch WP III, Zhao Y, Yu A (2007) Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US. Int J Impot Res 19:95–103CrossRefPubMed Rajfer J, Aliotta PJ, Steidle CP, Fitch WP III, Zhao Y, Yu A (2007) Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US. Int J Impot Res 19:95–103CrossRefPubMed
8.
Zurück zum Zitat Seftel AD, Shinghal R, Kim ED, Samuels SM, Ni X, Burns PR (2013) Retrospective analysis of the efficacy and safety of once-daily tadalafil in patient subgroups: men with mild vs moderate ED and aged < 50 vs > 50 years. Int J Impot Res 25(3):91–98. https://doi.org/10.1038/ijir.2012.40 (Epub 2012 Dec 6) CrossRefPubMed Seftel AD, Shinghal R, Kim ED, Samuels SM, Ni X, Burns PR (2013) Retrospective analysis of the efficacy and safety of once-daily tadalafil in patient subgroups: men with mild vs moderate ED and aged < 50 vs > 50 years. Int J Impot Res 25(3):91–98. https://​doi.​org/​10.​1038/​ijir.​2012.​40 (Epub 2012 Dec 6) CrossRefPubMed
9.
Zurück zum Zitat Bayraktar Z, Albayrak S (2017) Blood platelet activity in men with vasculogenic erectile dysfunction. Arch Ital Urol Androl 89(1):51–54CrossRefPubMed Bayraktar Z, Albayrak S (2017) Blood platelet activity in men with vasculogenic erectile dysfunction. Arch Ital Urol Androl 89(1):51–54CrossRefPubMed
14.
Zurück zum Zitat Otunctemur A, Bozkurt M, Besiroglu H, Polat EC, Ozcan L, Ozbek E (2015) Erectile dysfunction is positively correlated with mean platelet volume and platelet count, but not with eosinophil count in peripheral blood. Urol J. 12(5):2347–2352PubMed Otunctemur A, Bozkurt M, Besiroglu H, Polat EC, Ozcan L, Ozbek E (2015) Erectile dysfunction is positively correlated with mean platelet volume and platelet count, but not with eosinophil count in peripheral blood. Urol J. 12(5):2347–2352PubMed
17.
Zurück zum Zitat Sönmez MG, Göğer YE, Sönmez LÖ, Aydın A, Balasar M, Kara C (2016) Can eosinophil count, platelet count, and mean platelet volume be a positive predictive factor in penile arteriogenic erectile dysfunction etiopathogenesis? Am J Mens Health (pii: 1557988316679575. Epub ahead of print) Sönmez MG, Göğer YE, Sönmez LÖ, Aydın A, Balasar M, Kara C (2016) Can eosinophil count, platelet count, and mean platelet volume be a positive predictive factor in penile arteriogenic erectile dysfunction etiopathogenesis? Am J Mens Health (pii: 1557988316679575. Epub ahead of print)
19.
Zurück zum Zitat Dong JY, Zhang YH, Qin LQ (2011) Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol 58:1378–1385CrossRefPubMed Dong JY, Zhang YH, Qin LQ (2011) Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol 58:1378–1385CrossRefPubMed
21.
22.
Zurück zum Zitat Endler G, Klimesch A, Sunder-Plassmann H et al (2002) Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 117:399–404CrossRefPubMed Endler G, Klimesch A, Sunder-Plassmann H et al (2002) Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 117:399–404CrossRefPubMed
23.
Zurück zum Zitat Rosen RC, Cappelleri JC, Gendrano N III (2002) The international index of erectile function (IIEF): a state-of-the-science review. Int J Impot Res 14(4):226–244CrossRefPubMed Rosen RC, Cappelleri JC, Gendrano N III (2002) The international index of erectile function (IIEF): a state-of-the-science review. Int J Impot Res 14(4):226–244CrossRefPubMed
24.
Zurück zum Zitat Rosen RC, Allen KR, Ni X, Araujo AB (2011) Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale. Eur Urol 60(5):1010–1016CrossRefPubMed Rosen RC, Allen KR, Ni X, Araujo AB (2011) Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale. Eur Urol 60(5):1010–1016CrossRefPubMed
25.
Zurück zum Zitat Carson CC, Rajfer J, Eardley I et al (2004) The efficacy and safety of tadalafil: an update. BJU Int 93(9):1276–1281CrossRefPubMed Carson CC, Rajfer J, Eardley I et al (2004) The efficacy and safety of tadalafil: an update. BJU Int 93(9):1276–1281CrossRefPubMed
26.
Zurück zum Zitat Toda N, Ayajiki K, Okamura T (2005) Nitric oxide and penile erectile function. Pharmacol Ther 106(2):233–266CrossRefPubMed Toda N, Ayajiki K, Okamura T (2005) Nitric oxide and penile erectile function. Pharmacol Ther 106(2):233–266CrossRefPubMed
27.
Zurück zum Zitat Furuno T, Yamasaki F, Yokoyama T et al (2011) Effects of various doses of aspirin on platelet activity and endothelial function. Heart Vessels 26(3):267–273CrossRefPubMed Furuno T, Yamasaki F, Yokoyama T et al (2011) Effects of various doses of aspirin on platelet activity and endothelial function. Heart Vessels 26(3):267–273CrossRefPubMed
29.
Zurück zum Zitat Buvat J, Büttner H, Hatzimouratidis K et al (2013) Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafilonce a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction. J Sex Med 10(6):1592–1602. https://doi.org/10.1111/jsm.12130 (Epub 2013 Apr 2) CrossRefPubMed Buvat J, Büttner H, Hatzimouratidis K et al (2013) Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafilonce a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction. J Sex Med 10(6):1592–1602. https://​doi.​org/​10.​1111/​jsm.​12130 (Epub 2013 Apr 2) CrossRefPubMed
30.
Zurück zum Zitat Rajfer J, Aliotta PJ, Steidle CP et al (2007) Tadalafil dosed once a day men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US. Int J Impot Res 19(1):95–103 (Epub 2006 Jul 27) CrossRefPubMed Rajfer J, Aliotta PJ, Steidle CP et al (2007) Tadalafil dosed once a day men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US. Int J Impot Res 19(1):95–103 (Epub 2006 Jul 27) CrossRefPubMed
31.
Zurück zum Zitat Hafez G, Gonulalan U, Kosan M et al (2014) Acetylsalicylic acid protects erectile function in diabetic rats. Andrologia 46(9):997–1003CrossRefPubMed Hafez G, Gonulalan U, Kosan M et al (2014) Acetylsalicylic acid protects erectile function in diabetic rats. Andrologia 46(9):997–1003CrossRefPubMed
32.
Zurück zum Zitat Tauseef M, Shahid M, Sharma KK, Fahim M (2008) Antioxidative action of aspirin on endothelial function in hypercholesterolaemic rats. Basic Clin Pharmacol Toxicol 03(4):314–321CrossRef Tauseef M, Shahid M, Sharma KK, Fahim M (2008) Antioxidative action of aspirin on endothelial function in hypercholesterolaemic rats. Basic Clin Pharmacol Toxicol 03(4):314–321CrossRef
33.
Zurück zum Zitat Argiolas A, Melis MR, Stancampiano R, Gessa GL (1990) Oxytocin-induced penile erection and yawning: role of calcium and prostaglandins. Pharmacol Biochem Behav 35(3):601–605CrossRefPubMed Argiolas A, Melis MR, Stancampiano R, Gessa GL (1990) Oxytocin-induced penile erection and yawning: role of calcium and prostaglandins. Pharmacol Biochem Behav 35(3):601–605CrossRefPubMed
34.
Zurück zum Zitat Bornman MS, Dormehl IC, Franz RC, Du Plessis DJ, Jacobs DJ (1986) Platelets and thromboxane A2 in the pathogenesis of aging penile vascular changes and impotence. Arch Androl 17(3):233–234CrossRefPubMed Bornman MS, Dormehl IC, Franz RC, Du Plessis DJ, Jacobs DJ (1986) Platelets and thromboxane A2 in the pathogenesis of aging penile vascular changes and impotence. Arch Androl 17(3):233–234CrossRefPubMed
35.
Zurück zum Zitat Bornman MS, Dormehl IC, Du Plessis DJ, Du Plessis M, Jacobs DJ, Maree M (1986) Entrapment of platelets in the penis during and after erection. S Afr Med J 69(8):500–501PubMed Bornman MS, Dormehl IC, Du Plessis DJ, Du Plessis M, Jacobs DJ, Maree M (1986) Entrapment of platelets in the penis during and after erection. S Afr Med J 69(8):500–501PubMed
36.
Zurück zum Zitat Elnazer HY, Sampson A, Baldwin D (2015) Lithium and sexual dysfunction: an under-researched area. Hum Psychopharmacol 30(2):66–69CrossRefPubMed Elnazer HY, Sampson A, Baldwin D (2015) Lithium and sexual dysfunction: an under-researched area. Hum Psychopharmacol 30(2):66–69CrossRefPubMed
37.
Zurück zum Zitat Israilov S, Baniel J, Shmueli J et al (2004) Treatment program for erectile dysfunction in patients with cardiovascular diseases. Am J Cardiol 93(6):689–693CrossRefPubMed Israilov S, Baniel J, Shmueli J et al (2004) Treatment program for erectile dysfunction in patients with cardiovascular diseases. Am J Cardiol 93(6):689–693CrossRefPubMed
38.
Zurück zum Zitat Saroukhani S, Emami-Parsa M, Modabbernia A et al (2013) Aspirin for treatment of lithium-associated sexual dysfunction in men: randomized double-blind placebo-controlled study. Bipolar Disord 15(6):650–656CrossRefPubMed Saroukhani S, Emami-Parsa M, Modabbernia A et al (2013) Aspirin for treatment of lithium-associated sexual dysfunction in men: randomized double-blind placebo-controlled study. Bipolar Disord 15(6):650–656CrossRefPubMed
40.
Zurück zum Zitat Aversa A, Greco E, Bruzziches R, Pili M, Rosano G, Spera G (2007) Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study. Int J Impot Res 19:200–207CrossRefPubMed Aversa A, Greco E, Bruzziches R, Pili M, Rosano G, Spera G (2007) Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study. Int J Impot Res 19:200–207CrossRefPubMed
Metadaten
Titel
Efficacy and safety of combination of tadalafil and aspirin versus tadalafil or aspirin alone in patients with vascular erectile dysfunction: a comparative randomized prospective study
verfasst von
Zeki Bayraktar
Selami Albayrak
Publikationsdatum
22.06.2019
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 9/2019
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-019-02211-4

Weitere Artikel der Ausgabe 9/2019

International Urology and Nephrology 9/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.